Pharmaceutical Business review

Nutri Lifescience rolls out new Bergamonte product

A 2013 study in the International Journal of Cardiology found that the bergamot polyphenolic extract, when taken with the popular cholesterol-lowering rosuvastatin, enhanced the potency of the statin therapy. For a 30-day period, 77 patients with elevated low-density lipoprotein cholesterol (LDL-C) and triglycerides were assembled into separate groups that either received a placebo, rosuvastatin, Bergamonte extract alone or Bergamonte extract plus rosuvastatin.

Among other positive results, the researchers found that doses of rosuvastatin and Bergamonte together reduced total cholesterol, LDL-C, the LDL-C/HDL-C (high-density lipoprotein cholesterol) ratio and urinary mevalonate in patients that had concerning levels of blood fats, compared to the control group. Those that took Bergamonte extract alone showed considerably better results compared to those treated with rovustatin alone in terms of improving HDL-C and reducing triglycerides.

"Based on this study, and the fact that millions of Americans look to supplements to protect their cardiovascular health, we launched Bergamonte, in vegetable capsules, to address this mass need. We believe in using only the highest quality and naturally pure ingredients to help our customer achieve extraordinary health and maintain longevity," explains Jessica Eng, Founder of Nutri Lifescience

"Bergamot juice was traditionally recognized by the local population as a remedy for supporting healthy cholesterol level and cardiovascular health," says Eng, Founder of Nutri Lifescience. "The medicinal use of bergamot, forgotten for decades, is now being rediscovered through the work of Italian research universities and collaborating institutions."